Research and Markets: Nanotechnology in Drug Delivery 2011-2021 Report - Drug Delivery Set to Be One of Highest Nanotechnology Growth Sectors to 2021

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/9eb504/nanotechnology_in) has announced the addition of the "Nanotechnology in Drug Delivery 2011-2021" report to their offering.

Improved global health and a dramatic increase in the size of the global aging population combined with the inefficiency of traditional drug delivery methods and the application of life science principles to medical and biomedical research are the three big factors fueling the growth of the nanotech drug delivery market.

The healthcare market is poised to see some of the earliest benefits of nanotechnology, said Tim Harper, CEO of Cientifica Ltd., and within the next decade companies working on targeted drug delivery therapies will be able to realize many benefits, including patent extensions on existing drugs which nanotech drug delivery (NDD) will make far more effective, particularly in cancer therapy treatments."

Cientifica's Nanotechnology in Drug Delivery 2011 analyses and breaks down the current nanotechnology drug delivery market into geographic markets and its most relevant technologies. It forecasts total addressable markets and percent share of key NDD technologies to 2021 and supplies a technology adoption road map. Also included are several case studies of versatile and effective nanocarrier applications.

This report provides insight into the possibilities of targeted nanotech drug delivery and its market potential over the next decade.

This report provides an in-depth presentation of recent developments in nanotech drug delivery (NDD) and provides market opportunities to 2021, for the largest economies in the Americas, Asia, Europe and the rest of the world. Two market analyses are presented;

• The historical market growth for NDD between 2000-2010
• Market forecast for NDD from 2011 to 2021

Companies Mentioned:

• Accelrys
• AlphaRx Inc.
• Cephalon, Inc.
• GlaxoSmithKline
• IOTA NanoSolutions Ltd.
• Izon Science Ltd
• Kiadis Pharma
• Kuecept Ltd
• Lena Nanoceutics Ltd
• Life Technologies
• Lypro Biosciences
• Makefield Therapeutics, Inc.
• Medical Nanotechnologies, Inc.
• Merck Sharp & Dohme Corp.
• Nano Interface Technology, Inc
• Novartis Pharmaceuticals
• Novavax, Inc.
• NUCRYST Pharmaceuticals Corp.
• PAR Pharmaceutical, Inc.
• Particle Sciences, Inc.
• Pfizer
• Spectrum Pharmaceuticals, Inc.
• Spherics, Inc.
• The Dow Chemical Company (Dow)
• VYOME Biosciences

For more information visit http://www.researchandmarkets.com/research/9eb504/nanotechnology_in